Healthcare Oct 26, 2021 09:10 AM (GMT+8)
Billion Europe health news on October 26, recently, Nuo yimaier announced the completion of a billion yuan a + + round of financing. This round of financing is led by the industrial investment fund of West Lake University, followed by the old shareholders huiding investment, Su Gaoxin venture capital, Yiling capital, Junmao capital, Baofu investment and other investment institutions. It is mainly used to organize the in-depth layout of multiple implanted medical device product pipelines in the field of engineering and the implementation of internationalization strategy.
Since its establishment in March 2017, nuoyimair has completed several rounds of financing, with a cumulative financing of more than 500 million yuan. Among them, the a + round of 150 million yuan financing of nuoyimair was completed this year, led by CDH VGC (CDH innovation and Growth Fund).
Founded jointly by management and technical teams from China and Germany, nuoymaier is an innovative enterprise for R & D and production of implanted medical devices that "achieve human tissue repair and organ reconstruction". It has been shortlisted in the list of potential unicorn and unicorn cultivation enterprises at national, provincial, municipal and district levels. With "regenerative implantable medical devices" as the development core, Nuo Maier has implemented the development strategy of "multi technology, multi variety and multi track", and has arranged more than 10 product pipelines covering clinical departments such as oral cavity, ophthalmology, otolaryngology, surgery, medical aesthetics, reproductive medicine and sports medicine.
This text is a result of machine translation.